Four reasons why outsourcing may be the best option, and key factors to consider when selecting a provider.
Stephanie Morris
Advertisement
Stephanie Morris is scientific and marketing support for protEcol Services at Hospira
Articles by Stephanie Morris
Advertisement
Latest Updated Articles
The Case for Outsourcing Biologics Process DevelopmentDecember 1st 2008
Advertisement
Advertisement
Trending on BioPharm International
1
Alvotech, Advanz Submit First Eylea 8 mg Biosimilar Bid
2
Lilly's Mirikizumab (Omvoh) Hits New IBD Remission Goals
3
Shift to In Vivo CAR T Will Reshape Facility Design, Says Arcadis’ Emily Heffernan
4
The BioPharm Brief: New Approvals, Biosimilar Competition, and Deeper Remission
5